By Professor Shane T. Grey

Conference Abstracts

Steptoe R; Al-Kouba J; Coleman M; Jessup C; Starkey M; Overgaard N; Bridge J; Horvat J; Werder R; Walters S; Coates PT; Grey S; Thomas R; Wells J; Hansbro P; Phipps S; Davies J, 2016, 'Ablation of pathogenic memory T-cell responses by bone marrow-mediated gene therapy under immune-preserving conditions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 722 - 722, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610401644&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stead S; McInnes S; Kireta S; Rose P; Rojas-Canales D; Jesudason S; Grey S; Carroll R; Voelcker N; Coates P, 2016, 'Modification of DC Phenotype and Function via Targeted Porous Silicon Nanoparticles.', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, Vol. 16, pp. 275 - 275, presented at American Transplant Congress, MA, Boston, 11 June 2016 - 15 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383373902205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chandrakanthan V; Yeola A; Kwan JC; Oliver RA; Qiao Q; Kang YC; Zarzour P; Beck D; Boelen L; Unnikrishnan A; Villanueva JE; Nunez AC; Knezevic K; Palu C; Nasrallah R; Carnell M; Macmillan A; Whan R; Yu Y; Hardy P; Grey ST; Gladbach A; Delerue F; Ittner L; Mobbs R; Walkley CR; Purton LE; Ward RL; Wong JWH; Hesson LB; Walsh W; Pimanda JE, 2016, 'PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells', in PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 113, pp. E2306 - E2315, http://dx.doi.org/10.1073/pnas.1518244113

Pilgrim S; Zammit N; Walters S; Saito M; Zhang GY; Robert R; Alexander S; Mackay C; Grey S, 2015, 'Characterisation of the immunomodulatory action of novel anti-CXCR3 monoclonal antibody exploiting a conserved human and murine epitope', in XENOTRANSPLANTATION, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 22, pp. S122 - S122, presented at IPITA/IXA/CTS Joint Congress, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364594100297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pilgrim S; Zammit N; Walters S; Saito M; Zhang GY; Robert R; Alexander S; Mackay C; Grey S, 2015, 'CHARACTERISATION OF THE IMMUNOMODULATORY ACTION OF NOVEL ANTI-CXCR3 MONOCLONAL ANTIBODY EXPLOITING A CONSERVED HUMAN AND MURINE EPITOPE.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, Vol. 99, pp. S201 - S201, presented at Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625700294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stead S; Rose P; Kireta S; McInnes S; Rojas-Canales D; Jesudason S; Grey S; Carroll R; Voelcker N; Coates PT, 2015, 'Dendritic cell targeted therapy utilising porous silicon nanoparticles', in XENOTRANSPLANTATION, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 22, pp. S87 - S88, presented at IPITA/IXA/CTS Joint Congress, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364594100205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stead S; Rose P; Kireta S; McInnes S; Rojas-Canales D; Jesudason S; Grey S; Carroll R; Voelcker N; Coates PT, 2015, 'DENDRITIC CELL TARGETED THERAPY UTILISING POROUS SILICON NANOPARTICLES', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, Vol. 99, pp. S141 - S142, presented at Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625700202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sivanathan K; Rojas-Canales D; Hope C; Gronthos S; Grey S; Coates PT, 2015, 'GENE MICROARRAY COMPARATIVE ANALYSIS OF INTERFERON-GAMMA AND INTERLEUKIN-17A PRECONDITIONED HUMAN MESENCHYMAL STEM CELLS.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, Vol. 99, pp. S39 - S40, presented at Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625700055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zammit NW; Langley D; Walters SN; Malle EK; Pilgrim SM; Cultrone D; Christ D; Grey ST, 2015, 'Genetic polymorphisms in donor tissue determine transplant outcomes', in XENOTRANSPLANTATION, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 22, pp. S75 - S75, presented at IPITA/IXA/CTS Joint Congress, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364594100178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zammit NW; Langley D; Walters SN; Malle EK; Pilgrim SM; Cultrone D; Christ D; Grey ST, 2015, 'GENETIC POLYMORPHISMS IN DONOR TISSUE DETERMINE TRANSPLANT OUTCOMES.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, Vol. 99, pp. S122 - S122, presented at Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, AUSTRALIA, Melbourne, 15 November 2015 - 19 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stead S; Kireta S; McInnes S; Rose P; Rojas-Canales D; Jesudason S; Grey S; Carroll R; Voelcker N; Coates PT, 2015, 'DC TARGETED CELL THERAPY.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Lorne, Vol. 99, pp. S11 - S11, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), AUSTRALIA, Lorne, 11 November 2015 - 13 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368625900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhang G; Wang Y; Hu M; Sawyer A; Zhou J; Grey S; Alexander S, 2015, 'IL-2/IL-2 Ab Complex Leads to Long-Term Tolerance in a Treg Dependent DST Model of Skin Allograft Transplantation in Which DST and Timing of the Antibody Complex Are Crucial', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, PA, Philadelphia, Vol. 15, presented at American Transplant Congress, PA, Philadelphia, 02 May 2015 - 06 May 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370124200244&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McGuire H; King CK; Liuwantara D; Zahra DG; Grey S, 2005, 'Promoter polymorphisms in the NOD IL-21 gone', in Tissue Antigens, Blackwell Munksgaard, Vol. 66, pp. 491 - 491

Preprints

Tobler R; Souilmi Y; Huber C; Bean N; Turney C; Cooper A; Grey S, 2021, Genetic and climatic factors in the dispersal of Anatomically Modern Humans Out of Africa, http://dx.doi.org/10.21203/rs.3.rs-800178/v1

Zammit NW; Wong YY; Walters S; Warren J; Barry SC; Grey ST, 2020, RelA Governs a Network of Islet-Specific Metabolic Genes Necessary for Beta-Cell Function, http://dx.doi.org/10.2139/ssrn.3733072

Zammit N; Siggs OM; Gray P; King C; Christ D; Goodnow CC; Grey S; Cowley M; Craig M; Dinger M; Ziegler J; Villanueva J; Cultrone D; Brink R, 2019, Phospho-tuning immunity through Denisovan, modern human and mouse TNFAIP3 gene variants, http://dx.doi.org/10.1101/589507

Cultrone D; Zammit WN; Self E; Postert B; Han JZ; Bailey J; Warren J; Croucher DR; Kikuchi K; Bogdanovic O; Chtanova T; Hesselson D; Grey ST, A zebrafish functional genomics model to investigate the role of human A20 variants in vivo, http://dx.doi.org/10.1101/2020.02.23.961763

Zammit NW; Walters SN; Seeberger KL; Korbutt GS; Grey ST, A20 is an immune tolerance factor that can determine islet transplant outcomes, http://dx.doi.org/10.1101/770834

Souilmi Y; Tobler R; Johar A; Williams M; Grey ST; Schmidt J; Teixeira JC; Rohrlach A; Tuke J; Johnson O; Gower G; Turney C; Cox M; Cooper A; Huber CD, Admixture has obscured signals of historical hard sweeps in humans, http://dx.doi.org/10.1101/2020.04.01.021006

Campbell JM; Walters SN; Habibalahi A; Mahbib SB; Anwer AG; Grey ST; Goldys EM, Autofluorophores Assessed by Hyperspectral Microscopy Indicate Perturbation and Transplant Viability in Pancreatic Islets, http://dx.doi.org/10.21203/rs.3.rs-2058969/v1

Zammit NW; Gray PE; Siggs OM; Yap JY; Russell A; Cultrone D; Warren J; Walters SN; Brink R; Zahra D; Burnett DL; Gayevskiy V; Minoche AE; Ziegler JB; Craig ME; Wong M; Benitez-Aguirre P; Teo J; Cowley MJ; Dinger ME; Tangye SG; Burke C; Phan TG; Goodnow CC; Grey ST, Environmental and genetic disease modifiers of haploinsufficiency of A20, http://dx.doi.org/10.1101/2022.03.19.485004

Yam AO; Bailey J; Lin F; Jakovija A; Counoupas C; Triccas JA; Gunzer M; Bald T; Grey ST; Chtanova T, Microbial activation converts neutrophils into anti-tumor effectors, http://dx.doi.org/10.1101/2020.08.21.259051

Ghimire K; Kale A; Li J; Julovi SM; O’Connell P; Grey ST; Hawthorne WJ; Gunton JE; Rogers NM, Novel metabolic role for CD47 in pancreatic β-cell insulin secretion and islet transplant outcomes, http://dx.doi.org/10.1101/2022.07.22.501201

Other

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2025, Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.30699957

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2025, Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.30699951

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2025, Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.30699948

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2025, Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.30699945

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2025, Supplementary Data from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.30699942

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2025, Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.30699939

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 1 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027266.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 1 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027266

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 2 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027263

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 2 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027263.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 3 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027260

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 3 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027260.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 4 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027257

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Suppl video 4 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027257.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Supplementary Data from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027254

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Supplementary Data from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027254.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Supplementary Table 1 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027251

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2024, Supplementary Table 1 from Neutrophil conversion to a tumor-killing phenotype underpins effective microbial therapy, http://dx.doi.org/10.1158/0008-5472.27027251.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Data from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.c.6599657.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Data from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.c.6599657

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633202

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633202.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633199.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633199

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633196.v1

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633196

Yam AO; Bailey J; Lin F; Jakovija A; Youlten SE; Counoupas C; Gunzer M; Bald T; Woodruff TM; Triccas JA; Goldstein LD; Gallego-Ortega D; Grey ST; Chtanova T, 2023, Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy, http://dx.doi.org/10.1158/0008-5472.22633193.v1

Back to profile page